Kerry Mello-Parker, Director of Clinical Compliance for Rare & Complex Therapies, Shields Health Solutions, discusses the benefits of an integrated care model for high-risk diseases.
As Ms. Mello-Parker explains, Shields Health Solutions works with a national network of health systems to optimize patient outcomes. Their approach individually addresses each disease and patient’s unique needs. Shields’ pharmacy integration model allows greater access to specialty medications to patients while reducing out-of-pocket expenses. Shields engages with patients at the clinic and through telehealth to educate them on the importance of therapy adherence and completing routine lab work. Clinical pharmacists at Shields provide side effect mitigation tactics, monitor drug interactions, and analyze lab results to optimize treatment. Additionally, their clinical pharmacists investigate patient insurance benefits, complete prior authorizations, and identify financial assistance opportunities.
To stay up to date with the latest news on rare diseases, follow us on Twitter @CheckRare.
